{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:30:09Z","timestamp":1773721809459,"version":"3.50.1"},"reference-count":37,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7200","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T08:24:57Z","timestamp":1508228697000},"source":"Crossref","is-referenced-by-count":6,"title":["Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models"],"prefix":"10.3892","author":[{"given":"Megumi","family":"Morimoto","sequence":"first","affiliation":[{"name":"Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Integrated Technology Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Hara","sequence":"additional","affiliation":[{"name":"Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuo","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"key":"key20200714001305_b1-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20200714001305_b2-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"key20200714001305_b3-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"key20200714001305_b4-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jcsm.12010","article-title":"Understanding and managing cancer-related weight loss and anorexia: Insights from a systematic review of qualitative research","volume":"6","author":"Cooper","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20200714001305_b5-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200714001305_b6-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"key20200714001305_b7-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/MCO.0b013e3283455e21","article-title":"Cancer cachexia therapy: A key weapon in the fight against cancer","volume":"14","author":"Coss","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"key20200714001305_b8-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: Clinical implications, diagnosis, and emerging treatment strategies","volume":"62","author":"Dodson","year":"2011","journal-title":"Annu Rev Med"},{"key":"key20200714001305_b9-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1517\/14656566.2015.1079621","article-title":"Advances in pharmacologic strategies for cancer cachexia","volume":"16","author":"Madeddu","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"key20200714001305_b10-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/14712598.2016.1208168","article-title":"Novel therapeutic options for cachexia and sarcopenia","volume":"16","author":"Molfino","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"key20200714001305_b11-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/cncr.22339","article-title":"The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: A pilot study","volume":"107","author":"Strasser","year":"2006","journal-title":"Cancer"},{"key":"key20200714001305_b12-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200714001305_b13-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"key20200714001305_b14-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"10","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"key20200714001305_b15-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.bmc.2015.03.032","article-title":"Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I","volume":"23","author":"Aikawa","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"key20200714001305_b16-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/jcsm.12008","article-title":"Differences in food intake of tumor-bearing cachectic mice are associated with hypothalamic serotonin signaling","volume":"6","author":"Dwarkasing","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20200714001305_b17-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/SPC.0000000000000233","article-title":"Animal models for cancer cachexia","volume":"10","author":"Ballar\u00f2","year":"2016","journal-title":"Curr Opin Support Palliat Care"},{"key":"key20200714001305_b18-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20200714001305_b19-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1439-0264.2003.00441.x","article-title":"The effect of testosterone on gastrocnemius muscle fibres in growing and adult male and female rats: A histochemical, morphometric and ultrastructural study","volume":"32","author":"Ust\u00fcnel","year":"2003","journal-title":"Anat Histol Embryol"},{"key":"key20200714001305_b20-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1159\/000329184","article-title":"Growth hormone and testosterone: Anabolic effects on muscle","volume":"76","author":"Urban","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"key20200714001305_b21-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mce.2011.08.008","article-title":"Tissue- and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice","volume":"352","author":"De Gendt","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"key20200714001305_b22-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1016\/j.bmc.2017.04.018","article-title":"Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate","volume":"25","author":"Aikawa","year":"2017","journal-title":"Bioorg Med Che"},{"key":"key20200714001305_b23-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1615\/CritRevOncog.v17.i3.30","article-title":"Counteracting inflammation: A promising therapy in cachexia","volume":"17","author":"Argiles","year":"2012","journal-title":"Crit Rev Oncog"},{"key":"key20200714001305_b24-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.exger.2006.08.013","article-title":"Modulation of overload-induced inflammation by aging and anabolic steroid administration","volume":"41","author":"Thompson","year":"2006","journal-title":"Exp Gerontol"},{"key":"key20200714001305_b25-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2217\/fon.13.273","article-title":"Enobosarm (GTx-024, S-22): A potential treatment for cachexia","volume":"10","author":"Srinath","year":"2014","journal-title":"Future Oncol"},{"key":"key20200714001305_b26-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13539-012-0066-6","article-title":"Cancer cachexia and anabolic interventions: A case report","volume":"3","author":"Dillon","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20200714001305_b27-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s00520-013-1832-5","article-title":"Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: A preliminary double-blind placebo-controlled trial","volume":"21","author":"Del Fabbro","year":"2013","journal-title":"Support Care Cancer"},{"key":"key20200714001305_b28-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0022-5347(17)45620-5","article-title":"Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762","volume":"135","author":"de Vooqt","year":"1986","journal-title":"J Urol"},{"key":"key20200714001305_b29-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/jcb.25751","article-title":"Tissue selective androgen receptor modulators (SARMs) increase pelvic floor muscle mass in ovariectomized mice","volume":"118","author":"Ponnusamy","year":"2017","journal-title":"J Cell Biochem"},{"key":"key20200714001305_b30-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsbmb.2016.04.007","article-title":"A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice","volume":"163","author":"Chisamore","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20200714001305_b31-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/1471-2474-15-291","article-title":"Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization","volume":"15","author":"Blanqu\u00e9","year":"2014","journal-title":"BMC Musculoslelet Disord"},{"key":"key20200714001305_b32-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2013.10.042","article-title":"A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate","volume":"720","author":"Akita","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"key20200714001305_b33-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsbmb.2012.10.015","article-title":"Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator","volume":"134","author":"Zhang","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20200714001305_b34-ol-0-0-7200","doi-asserted-by":"crossref","first-page":"e010","DOI":"10.1621\/nrs.06010","article-title":"Selective androgen receptor modulators in preclinical and clinical development","volume":"6","author":"Narayanan","year":"2008","journal-title":"Nucl Recept Signal"},{"key":"key20200714001305_b35-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1210\/me.2008-0160","article-title":"Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways","volume":"22","author":"Narayanan","year":"2008","journal-title":"Mol Endocrinol"},{"key":"key20200714001305_b36-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study design and rationale for phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"key20200714001305_b37-ol-0-0-7200","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nbt0816-888b","article-title":"No longer going to waste","volume":"34","author":"Garber","year":"2016","journal-title":"Nat Biotechnol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:47:52Z","timestamp":1594687672000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7200","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]}}}